Patent: 10,100,106
✉ Email this page to a colleague
Summary for Patent: 10,100,106
Title: | Single domain serum albumin binding protein |
Abstract: | Disclosed herein are single domain serum albumins binding proteins with improved thermal stability, binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single domain serum albumin binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided. |
Inventor(s): | Dubridge; Robert B. (Belmont, CA), Lemon; Bryan D. (Mountain View, CA), Austin; Richard J. (San Francisco, CA), Evnin; Luke (San Francisco, CA), Guenot; Jeanmarie (San Francisco, CA) |
Assignee: | HARPOON THERAPEUTICS, INC. (South San Francisco, CA) |
Application Number: | 15/600,582 |
Patent Claims: | see list of patent claims |
Details for Patent 10,100,106
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2036-05-20 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2036-05-20 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2036-05-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |